Paradoxically, serum HDL-cholesterol levels are lowered by concomitant treatment with fenofibrate plus rosiglitazone

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1455, 2004-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paradoxically, serum HDL-cholesterol levels are lowered by concomitant treatment with fenofibrate and rosiglitazone

Reactions Weekly, Vol. 1, Iss. 1019, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Fenofibrate/rosiglitazone interaction: Decreased HDL cholesterol levels: 3 patients

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Oxymetholone: First report of a decrease in HDL-cholesterol levels: case report

Reactions Weekly, Vol. 1, Iss. 1177, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Micronized Fenofibrate in Dyslipidemia: A Focus on Plasma High-Density Lipoprotein Cholesterol (HDL-C) Levels

By Sharpe M. Ormrod D. Jarvis B.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

The use of fibric acid derivatives combined with rosiglitazone appears to decrease HDL cholesterol levels in patients with diabetes mellitus (DM)

Reactions Weekly, Vol. 1, Iss. 1184, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite